TRPV3 in Drug Development

By Broad Lisa M.   Mogg Adrian J.   Eberle Elizabeth   Tolley Marcia   Li Dominic L.   Knopp Kelly L.  

Pharmaceuticals, Vol. 9, Iss. 3, 2016-09 ,pp. : 55-55

MDPI

Access to resources Recommend Favorite

Analytical Challenges and Regulatory Requirements for Nasal Drug Products in Europe and the U.S.

By Trows Sabrina   Wuchner Klaus   Spycher Rene   Steckel Hartwig  

Pharmaceutics, Vol. 6, Iss. 2, 2014-04 ,pp. : 195-219

MDPI

Access to resources Recommend Favorite

Pharmacogenomics in Pediatric Oncology: Review of Gene—Drug Associations for Clinical Use †

By Mlakar Vid   Huezo-Diaz Curtis Patricia   Satyanarayana Uppugunduri Chakradhara Rao   Krajinovic Maja   Ansari Marc  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1502-1502

MDPI

Access to resources Recommend Favorite

Molecular Science for Drug Development and Biomedicine

By Zhong Wei-Zhu   Zhou Shu-Feng  

International Journal of Molecular Sciences, Vol. 15, Iss. 11, 2014-11 ,pp. : 20072-20078

MDPI

Access to resources Recommend Favorite

Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens

By Rodi Maria   Dimisianos Nikolaos   de Lastic Anne-Lise   Sakellaraki Panagiota   Deraos George   Matsoukas John   Papathanasopoulos Panagiotis   Mouzaki Athanasia  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-08 ,pp. : 1398-1398

MDPI

Access to resources Recommend Favorite